The IPO Buzz: ADARx Pharmaceuticals Prices Upsized IPO at $17 – High End – & Stock Pops
ADARx Pharmaceuticals (ADRX) upsized its IPO at pricing to 26.25 million shares – up from 21.88 million shares in the prospectus - and priced the IPO at $17.00 – the high end of its $15.00-to-$17.00 range – to raise $446.25 million on Thursday night, Sept. 24, 2026. At pricing, ADARx Pharmaceuticals (ADRX) had a market cap of $1.81 billion. ADARx Pharmaceuticals (ADRX) stock jumped..
Read more September 24, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| ADARx Pharmaceuticals | ADRX | 26.3 | $ 446.3 mil | 9/25/2026 Priced | S/O | S/O |
| Bluerock Acquisition Corp. II | BRRKU | 15.0 | $ 150.0 mil | 9/25/2026 Priced | S/O | S/O |
| Accelevation Holdings Corp. | ACCV | 30.0 | $ 660.0 mil | 9/30/2026 Wednesday | S/O | S/O |
Last 100 IPOs - September 24, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 49 |
| Number Down: | 50 |
| Number Unchanged: | 1 |
| Percentage Change From Issue Price: | 7.86% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - September 24, 2026
| Number of IPOs priced (Excluding 148 units) : | 123 |
| Number Up: | 59 |
| Number Down: | 63 |
| Number Unchanged: | 1 |
| Total Return From Issue Price: | 7.68% |
| The Nasdaq Composite Index YTD % Change | 35.22% |